DEBRA TAYLOR: Open Payments
NPI 1245792522 · LEITCHFIELD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,370 in 56 payments from 18 companies in 2025. Trend: 2023 $276 · 2024 $1,792 · 2025 $1,370
Food & beverage: $1,370
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $281 |
| PFIZER INC. | 14 | $274 |
| AstraZeneca Pharmaceuticals LP | 4 | $207 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $134 |
| ABBVIE INC. | 6 | $116 |
| Lilly USA, LLC | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
Products named: NURTEC ODT, Wegovy, AIRSUPRA, Kerendia, JARDIANCE, BREZTRI, Ozempic, UBRELVY.
Industry payments across KY — which companies pay providers there.
